Patents by Inventor Anthony Sebastian

Anthony Sebastian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5710365
    Abstract: There is provided soybean protein products of significantly lowerstachyose content as a function of an improved soybean having a seed stachyose content of less than 50 .mu.mol/g. Improved soybean lines are provided as are methods of using such reduced stachyose soybeans.
    Type: Grant
    Filed: January 31, 1995
    Date of Patent: January 20, 1998
    Assignee: E. I. Du Pont de Nemours and Company
    Inventors: Phillip Scott Kerr, Scott Anthony Sebastian
  • Patent number: 5498428
    Abstract: Novel methods are provided for treating hypertension in humans which comprise administering therapeutic amounts of pharmaceutically-acceptable non-halide salts of potassium. Preferred salts are potassium bicarbonate and potassium phosphate. The methods may also be used to lower the blood pressure of normotensive individuals. Dietary supplementation is a preferred and convenient method of administration.
    Type: Grant
    Filed: January 10, 1994
    Date of Patent: March 12, 1996
    Assignee: The Regents of the University of California
    Inventors: R. Curtis Morris, Jr., Anthony Sebastian
  • Patent number: 5496569
    Abstract: A method for simultaneously treating osteoporosis and hypertension in the same individual by the administration of pharmaceutically acceptable alkalinizing potassium salts, such as potassium bicarbonate, preferably in the form of a dietary supplement.
    Type: Grant
    Filed: April 2, 1993
    Date of Patent: March 5, 1996
    Assignee: The Regents of the University of California
    Inventors: R. Curtis Morris, Jr., Anthony Sebastian
  • Patent number: 5281424
    Abstract: Novel methods are provided for treating hypertension in humans which comprise administering therapeutic amounts of pharmaceutically-acceptable non-halide salts of potassium. Preferred salts are potassium bicarbonateGOVERNMENT SUPPORTThis invention was made with Government support under Grant No. M01-RR0079 awarded by the National Institutes of Health. The Government has certain rights in this invention.
    Type: Grant
    Filed: May 29, 1991
    Date of Patent: January 25, 1994
    Assignee: The Regents of the University of California
    Inventors: R. Curtis Morris, Jr., Anthony Sebastian
  • Patent number: 5171583
    Abstract: Novel methods are provided for treating osteoporosis in humans, comprising administering therapeutic amounts of pharmaceutically-acceptable alkalinizing salts of potassium. The preferred salt is potassium bicarbonate. The methods may also be used to prevent or delay the onset of osteoporosis. Dietary supplementation is a preferred and convenient method of administration.
    Type: Grant
    Filed: October 17, 1989
    Date of Patent: December 15, 1992
    Assignee: The Regents of the University of California
    Inventors: R. Curtis Morris, Jr., Anthony Sebastian